CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

被引：0

作者：

Harrison, Stephen A. ^{[1
]}

Lawitz, Eric J. ^{[2
]}

Wong, Vincent Wai-Sun ^{[3
]}

Anstee, Quentin M. ^{[4
]}

Trauner, Michael H. ^{[5
]}

Romero-Gomez, Manuel ^{[6
]}

Bhandari, Bal ^{[7
]}

Abdelmalek, Manal F. ^{[8
]}

Sanyal, Arun J. ^{[9
]}

Patel, Keyur ^{[10
]}

Leroy, Vincent ^{[11
]}

Bureau, Christophe ^{[12
]}

Sasso, Magali ^{[13
]}

Fournier, Celine D. ^{[13
]}

Sandrin, Laurent ^{[13
]}

Han, Ling ^{[14
]}

Li, Georgia ^{[14
]}

Kersey, Kathryn ^{[14
]}

Camargo, Marianne ^{[14
]}

Djedjos, Stephen ^{[14
]}

Myers, Robert P. ^{[14
]}

Goodman, Zackary ^{[15
]}

Younossi, Youssef ^{[16
]}

机构：

[1] Pinnacle Clin Res, San Antonio, TX USA

[2] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA

[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

[5] Med Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria

[6] Univ Seville, Virgen Del Rocio Univ Hosp, Digest Dis Dept, Ciberehd,Seliver Grp,IBIS, Seville, Spain

[7] Delta Res Partners, Bastrop, LA USA

[8] Duke Univ, Durham, NC 27706 USA

[9] Virginia Commonwealth Univ, Richmond, VA 23284 USA

[10] Univ Hlth Network, Toronto, ON, Canada

[11] Grenoble Univ Hosp, Hepatol Dept, Grenoble, France

[12] CHU Toulouse, Toulouse, France

[13] Echosens, Paris, France

[14] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[15] Inova Fairfax Hosp, Falls Church, VA USA

[16] Inova Hlth Syst, Falls Church, VA USA

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2295

引用

页码：1349A / 1350A

页数：2

共 50 条

[41] Predictors of nonalcoholic steatohepatitis in Japanese patients: Thioredoxin and NASH
Okanoue, T
Yamauchi, N
Furutani, M
Hirohama, A
Sumida, Y
Nakashima, T
NASH AND NUTRITIONAL THERAPY, 2005, : 64 - 72
[42] Genetic background of Japanese patients with nonalcoholic steatohepatitis (NASH)
Saibara, T
Namikawa, C
Zhang, SP
Ma, RH
Nozaki, Y
Nemoto, Y
Ono, M
Akisawa, N
Iwasaki, S
Hiroi, M
Enzan, H
Onishi, S
NASH AND NUTRITIONAL THERAPY, 2005, : 58 - 63
[43] Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis
Sourianarayanane, Achuthan
Talluri, Jyothsna
Humar, Abinav
McCullough, Arthur J.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (05) : 516 - 523
[44] ROUTINELY AVAILABLE NONINVASIVE TESTS PERFORM WELL IN IDENTIFYING PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: DATA FROM THE TARGET-NASH OBSERVATIONAL COHORT
Barritt, Alfred Sidney
Lok, Anna S.
Reddy, K. Rajender
Weiss, L. Michael
Firpi, Roberto J.
Thuluvath, Paul J.
Trinh, Huy N.
Djedjos, Stephen
Haubrich, Richard
Billin, Andrew
Koch, Bruce, II
Zink, Richard
Sanyal, Arun J.
Cusi, Kenneth
Neuschwander-Tetri, Brent A.
HEPATOLOGY, 2019, 70 : 1049A - 1049A
[45] Three-dimensional observation on the evolution of fibrosis in the relatively early-to-mid stage of nonalcoholic steatohepatitis (NASH)
Hano, H.
Chiba, S.
Lu, T.
Nagatsuma, K.
Inagaki, T.
HISTOPATHOLOGY, 2008, 53 : 258 - 258
[46] Serum lysyl oxidase-like-2 (sLOXL2) levels correlate with fibrosis stage in patients with nonalcoholic steatohepatitis (NASH)
Harrison, Stephen A.
Goodman, Zachary D.
Ratziu, Vlad
Loomba, Rohit
Diehl, Anna Mae
Lawitz, Eric
Hinrichsen, Holger
Bambha, Kiran
Abdelmalek, Manal F.
Myers, Robert P.
Schall, Raul E. Aguilar
Subramanian, Mani
McHutchison, John G.
Afdhal, Nezam H.
Muir, Andrew J.
HEPATOLOGY, 2015, 62 : 910A - 910A
[47] Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials
Lampertico, P.
Younossi, Z. M.
Lawitz, E. J.
Alkhouri, N.
Wong, V. Wai-Sun
Romero-Gomez, M.
Okanoue, T.
Trauner, M.
Kersey, K.
Li, G.
Subramanian, G. M.
Myers, R. P.
Djedjos, C. S.
Han, L.
Chen, G.
Nguyen, T.
Kohli, A.
Bzowej, N.
Younes, Z.
Sarin, S.
Shiffman, M. L.
Harrison, S. A.
Goodman, Z.
Afdhal, N. H.
Stepanova, M.
Anstee, Q. M.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E25 - E26
[48] ALGORITHMS USING NONINVASIVE TESTS CAN ACCURATELY IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: DATA FROM THE STELLAR CLINICAL TRIALS
Wong, Vincent Wai-Sun
Younossi, Zobair
Lawitz, Eric
Alkhouri, Naim
Romero-Gomez, Manuel
Okanoue, Takeshi
Trauner, Michael
Kersey, Kathryn
Li, Georgia
Subramanian, Mani
Myers, Robert
Djedjos, Stephen
Han, Ling
Chen, Guang
Tuan Nguyen
Kohli, Anita
Bzowej, Natalie
Younes, Ziad
Sarin, Shiv
Shiffman, Mitchell
Harrison, Stephen
Goodman, Zachary
Afdhal, Nezam
Stepanova, Maria
Anstee, Quentin
GUT, 2019, 68 : A135 - A136
[49] Algorithms Using Noninvasive Tests Can Accurately Identify Patients with Advanced Fibrosis Due to Nash: Data from the Stellar Clinical Trials
Younossi, Zobair M.
Lawitz, Eric
Alkhouri, Naim
Wong, Vincent Wai-Sun
Romero-Gomez, Manuel
Okanoue, Takeshi
Trauner, Michael H.
Kersey, Kathryn
Li, Georgia
Subramanian, G. Mani
Myers, Robert P.
Djedjos, Stephen
Han, Ling
Chen, Guang
Tuan Nguyen
Kohli, Anita
Bzowej, Natalie H.
Younes, Ziad
Sarin, Shiv Kumar
Shiffman, Mitchell L.
Harrison, Stephen A.
Goodman, Zachary D.
Stepanova, Maria
Afdhal, Nezam H.
Anstee, Quentin M.
HEPATOLOGY, 2018, 68 (06) : 1452A - 1453A
[50] CHANGES IN FIBROSIS, BUT NOT THE NAFLD ACTIVITY SCORE (NAS), ARE ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS
Sanyal, Arun
Harrison, Stephen A.
Ratziu, Vlad
Abdelmalek, Manal F.
Diehl, Anna Mae
Caldwell, Stephen H.
Shiffman, Mitchell L.
Aguilar, Raul
Jia, Catherine
McColgan, Bryan J.
Natha, Macky
Myers, Robert P.
Subramanian, Mani
McHutchison, John
Muir, Andrew J.
Afdhal, Nezam H.
Bosch, Jaime
Goodman, Zachary
GASTROENTEROLOGY, 2017, 152 (05) : S1055 - S1055

← 1 2 3 4 5 →